SCHEMBL26074493

SCHEMBL26074493

CC(C)COc1ccc(-c2ccc(-c3cc(C(=O)O)c4cc(I)ccc4n3)nc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 9/20 0.48
▸ KDM4E B2RXH2 3/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ HPGD P15428 2/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ EIF4A1 P60842 2/20 0.44
▸ PDE10A Q9Y233 1/20 0.44
▸ HSD17B10 Q99714 3/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ NR1H4 Q96RI1 1/20 0.42
▸ HIF1A Q16665 2/20 0.41
▸ PTGES O14684 1/20 0.41
▸ ALOX5 P09917 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CASP7 P55210 1/20 0.41
▸ TARBP2 Q15633 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26074021 0.91 DHODH (0.55) DHODHKDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL26074531 0.90 DHODH (0.49) DHODHKDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL23590211 0.89 DHODH (0.56) DHODHKDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL26074463 0.89 KDM4E (0.58) DHODHKDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL26074491 0.88 MCL1 (0.45) DHODHKDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL26074473 0.88 KDM4E (0.56) DHODHKDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL26074608 0.86 DHODH (0.51) DHODHKDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL23590063 0.86 DHODH (0.48) DHODHKDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL26074524 0.84 DHODH (0.48) DHODHKDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL26074552 0.82 EIF4A1 (0.50) DHODHKDM4ESMN1; SMN2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD DHODH 1/4885KDM4E 1396/4885SMN1; SMN2 3677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback